Hubei Biocause Pharmaceutical (000627) — Financial Flexibility Index

Latest as of September 2023: 0.00x

Hubei Biocause Pharmaceutical (000627) has a Financial Flexibility Index of 0.00x as of September 2023. Free cash flow of CN¥286.56 Million (operating CF CN¥276.06 Million minus capex CN¥10.51 Million) represents 0% of total liabilities (CN¥272.50 Billion). Check asset allocation strategy of Hubei Biocause Pharmaceutical to assess the company's strategic physical and investment asset allocation.

Financial Flexibility Index

0.00x
Free Cash Flow / Total Liabilities

Free Cash Flow

CN¥286.56 Million
Operating CF − Capex

Total Liabilities

CN¥272.50 Billion
CNY

Capital Expenditures

CN¥10.51 Million
CNY

Hubei Biocause Pharmaceutical Financial Flexibility Index (2001–2023)

Historical Financial Flexibility Index trend for Hubei Biocause Pharmaceutical across 18 annual periods. See Hubei Biocause Pharmaceutical current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Annual Financial Flexibility Index for Hubei Biocause Pharmaceutical (2001–2023)

Year-by-year free cash flow to debt coverage for Hubei Biocause Pharmaceutical. For the full company profile including market capitalisation, see Hubei Biocause Pharmaceutical (000627) market capitalisation.

Year Flexibility Index Free Cash Flow (CNY) Operating CF Total Liabilities YoY Change
2023 0.04x CN¥9.60 Billion CN¥9.53 Billion CN¥268.30 Billion ▲ +18.7%
2022 0.03x CN¥7.66 Billion CN¥7.52 Billion CN¥254.00 Billion ▲ +53.1%
2021 0.02x CN¥4.46 Billion CN¥4.17 Billion CN¥226.43 Billion ▼ -81.4%
2020 0.11x CN¥21.74 Billion CN¥21.42 Billion CN¥204.81 Billion ▼ -38.1%
2019 0.17x CN¥29.32 Billion CN¥28.60 Billion CN¥170.92 Billion ▲ +71.2%
2018 0.10x CN¥15.26 Billion CN¥14.98 Billion CN¥152.24 Billion ▲ +841.3%
2017 0.01x CN¥1.21 Billion CN¥431.58 Million CN¥113.71 Billion ▼ -22.3%
2016 0.01x CN¥1.34 Billion CN¥-2.34 Billion CN¥97.48 Billion ▲ +243.7%
2015 -0.01x CN¥-5.97 Million CN¥-46.73 Million CN¥625.50 Million ▼ -102.5%
2013 0.38x CN¥274.33 Million CN¥130.53 Million CN¥720.71 Million ▼ -9.7%
2012 0.42x CN¥222.29 Million CN¥93.79 Million CN¥527.37 Million ▼ -8.5%
2011 0.46x CN¥216.32 Million CN¥66.95 Million CN¥469.47 Million ▼ -45.7%
2010 0.85x CN¥317.67 Million CN¥224.58 Million CN¥374.25 Million ▲ +112.3%
2007 0.40x CN¥183.32 Million CN¥118.56 Million CN¥458.52 Million ▼ -31.3%
2006 0.58x CN¥258.31 Million CN¥128.19 Million CN¥443.66 Million ▲ +183.8%
2005 0.21x CN¥73.17 Million CN¥48.66 Million CN¥356.70 Million ▼ -10.1%
2004 0.23x CN¥81.59 Million CN¥56.07 Million CN¥357.41 Million ▼ -25.0%
2001 0.30x CN¥68.77 Million CN¥37.30 Million CN¥226.09 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities